ICAM1 and melanoma: Because our results showed that ICAM-1 upregulation may be predictive not only of a proinflammatory melanoma secretome but also of an immunogenic TME, we then investigated whether ICAM-1high levels correlated with improved prognosis of patients with melanoma.